Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on POI
Total 0 results
Nothing found
Sponsors and Collaborators
Roongroj Bhidayasiri
Steven B. Kleiboeker
Universidad Mayor de San Simón (UMSS, Bolivia)
Donald B. Kohn, M.D.
Shaoxing Mashan Street Community Health Service Center
Didem OZKAL EMINOGLU
MYOR Ltd.
Nelson Mandela Academic Hospital
Maria de las Mercedes Perez Rodriguez
Pompeyo Stalin Alarcón Vigil
Shenzhen Core Medical Technology CO.,LTD.
Sub-Investigator: Łucja Bieleninik, PhD
Worabe Comprehensive Specialiazed Hospital
The Institute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, Barcelona
Saw Swee Hock School of Public Health
Pharmacy Board of Sierra Leone, Ministry of Health and Sanitation
Dr. Jochen Brack
Hospital Governador Celso Ramos
Sociedad Panameña de Hematología
Centre Hospitalier du Quebec
View Full List
Medical Conditions
Endoscopic Surveillance
Atherosclerosis Coronary Artery With Angina Pectoris
Control Nausea and Vomiting
Humerus Fracture Displaced Proximal
Poor Medication Adherence
Pharmacokinetics of Ipragliflozin
0.5-14 Year Old Children With Nephroblastoma
Bladder Recurrence
Neuroectodermal Tumor
Malignant Tumor of Urinary System (Disorder)
Macrocephaly Autism Syndrome
Memory Disorders
Urinary Bladder Neurogenic Dysfunction
Inoperable Stage III Non-small Cell Lung Cancer
Granulomatous Disease, Chronic
Parental
Root Abscess
Anticoagulant Prophylaxis/Therapy
Bladder Cancer Recurrent
Small Intestine Cancer
View Full List
Drug Interventions
Ceralasertib
Bupropion Extended Release Oral Tablet
SAR408701 (Tusamitamab ravtansine)
Cyclosporine A
Sparsentan
Clozapine 100 mg
Vehicle
Varenicline Controlled Release 1.2 mg
APG2575 800 mg
FTD regimen
Elafibranor 80mg
Letrozole
Rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)
Idelalisib
Salvinorin A
The drug "Rutan 0.1".
Everolimus
Fibrin Sealant
Campath 1H
Biphasic insulin aspart 30
View Full List
CROs by country
Contract Research Organizations in Croatia
Contract Research Organizations in Denmark
Contract Research Organizations in Gabon
Contract Research Organizations in Guinea
Contract Research Organizations in Kenya
Contract Research Organizations in Lebanon
Contract Research Organizations in Lithuania
Contract Research Organizations in Madagascar
Contract Research Organizations in Mozambique
Contract Research Organizations in Saint Lucia
Contract Research Organizations in Sri Lanka
Contract Research Organizations in Togo
Contract Research Organizations in United States
CRO list by country
CROs in United States
ERT
Quertle
FEFA
Emerson Resources
Lifetree Clinical Research
ABF Pharmaceutical Services
RCRI
NDA Regulatory Science (NDA Group)
Rho
Aagami
All CROs in United States
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe